INTERCEPT PHARMACEUTICALS IN
CUSIP 45845PAB4
Intercept Pharmaceuticals In has 8 institutional holders in Filings Flow’s 13F database, together reporting 48.14M shares worth $21M as of Q4 2022. The largest reported holders are Franklin Resources Inc, Weiss Asset Management LP, and Oaktree Capital Management LP.
Institutional Holders
8
Q4 2022
Reported Value
$21M
Ticker
unmapped
private placement or foreign
Quarters Tracked
5
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| PenderFund Capital Management Ltd.$639M AUM | 3.76% | $12,549 | 9.29M | Q3 2023OLDER |
| Context Capital Management, LLC$4.3B AUM | 1.81% | $22,612 | 23.1K | Q3 2023OLDER |
| Weiss Asset Management LP$5.9B AUM | 0.94% | $16M | 16.16M | Q3 2023OLDER |
| Anson Funds Management LP$2.3B AUM | 0.79% | $4M | 4.00M | Q3 2023OLDER |
| DG Capital Management, LLC$326M AUM | 0.59% | $1M | 1.10M | Q3 2023OLDER |
| Skaana Management L.P.$296M AUM | 0.48% | $2M | 2.00M | Q3 2023OLDER |
| AQR Arbitrage LLC$6.1B AUM | 0.27% | $6M | 6.13M | Q3 2023OLDER |
| OAKTREE CAPITAL MANAGEMENT LP$6.6B AUM | 0.10% | $7M | 7.29M | Q3 2023OLDER |
| GABELLI & Co INVESTMENT ADVISERS, INC.$674M AUM | 0.04% | $220,658 | 225.0K | Q3 2023OLDER |
| Calamos Advisors LLC$28.2B AUM | 0.03% | $5M | 5.00M | Q3 2023OLDER |
| FRANKLIN RESOURCES INC$408.3B AUM | 0.01% | $21M | 21.00M | Q3 2023OLDER |
| Russell Investments Group, Ltd.$93.1B AUM | 0.00% | $2M | 1.71M | Q3 2023OLDER |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC$481.0B AUM | 0.00% | $3M | 3.00M | Q4 2023 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.